Quantcast

Latest Hematology Stories

2014-09-02 12:29:39

BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients at risk of stroke in everyday clinical practice -- Data from nearly 12,500 patients enrolled in the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic research initiative, have illustrated that stroke prevention strategies for atrial...

Faster, Cheaper Test Developed For Sickle Cell Disease
2014-09-02 03:27:42

Harvard University Newly developed test can identify sickle cell disease in minutes and could be used in rural clinics around the globe Within minutes after birth, every child in the US undergoes a battery of tests designed to diagnose a host of conditions, including sickle cell disease. Thousands of children born in the developing world, however, aren't so lucky, meaning many suffer and die from the disease each year. A.J. Kumar hopes to put a halt to at least some of those deaths....

2014-09-02 08:30:31

Patients at higher risk of kidney problems due to existing diabetes were also evaluated for the effects of warfarin on kidney function RIDGEFIELD, Conn., Sept. 2, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a new post-hoc sub-analysis of the pivotal phase III RE-LY® trial assessing renal function change in patients with non-valvular atrial fibrillation (NVAF) treated with Pradaxa® (dabigatran etexilate mesylate) compared to warfarin. The...

2014-09-02 04:21:13

X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept. 2, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare, announced today results from the X-VeRT trial, demonstrating once-daily XARELTO(®) (rivaroxaban) may be an alternative to vitamin K antagonists (VKA) in treating and reducing the risk of blood clots in non-valvular atrial...

2014-08-28 12:29:37

BOSTON, Aug. 28, 2014 /PRNewswire/ -- The North American Thrombosis Forum (NATF), a non-profit organization dedicated to increasing public awareness of thrombosis and related cardiovascular diseases, is thrilled to welcome 7 renowned experts in cardiovascular medicine to speak at their Fall educational program, the 8(th) Annual Thrombosis Summit, on Saturday, September 20. The Thrombosis Summit will take place at the beautiful Fairmont Copley Plaza Hotel located in Copley Square in...

2014-08-28 12:29:36

MILWAUKEE, Aug. 28, 2014 /PRNewswire-USNewswire/ -- BloodCenter of Wisconsin's Diagnostic Laboratories today announced the availability of an innovative Erythroid Chimerism test to monitor erythroid lineage chimerism in patients with sickle cell disease (SCD) following allogeneic bone marrow transplantation. This allows the physician to directly gauge the success of the transplant in these patients and provides physicians with actionable information to guide patient care. Sickle cell...

2014-08-27 12:30:15

WASHINGTON, Aug. 27, 2014 /PRNewswire-USNewswire/ -- An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society of Hematology (ASH). Anemia is a condition that occurs when red blood cells are in short supply or do not function properly. When an individual has anemia,...

Aspirin May Reduce The Risk Of Blood Clots Reoccurring
2014-08-27 03:05:36

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation. In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood clots were monitored for at least two years. In the International Collaboration of Aspirin Trials for...

2014-08-25 08:27:37

-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014 Hot Line Session RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO(®) (rivaroxaban) in patients with non-valvular atrial...

2014-08-25 08:27:31

Hot Line session presentations to feature renal function data from pivotal RE-LY® trial and global GLORIA(TM)-AF registry updates RIDGEFIELD, Conn., Aug. 25, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that data from nine company-sponsored Pradaxa® (dabigatran etexilate mesylate) studies will be presented at the European Society of Cardiology (ESC) Congress 2014, August 30 to September 3 in Barcelona, Spain. The abstracts will feature data about the use...


Latest Hematology Reference Libraries

2012-06-14 04:12:14

Symbol: ZYGOP2 Group: Fern Family: Grammitidaceae Distribution: ZygophlebiaBishop distribution:USA+(PR) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Division   Pteridophyta – Ferns Class   Filicopsida Order   Polypodiales Family   Grammitidaceae – Kihi Fern family Genus   Zygophlebia Bishop – octopus fern

2012-06-14 07:28:41

Symbol: ZATH Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylumthomasianum(Krug & Urb.) Krug & Urb. ex P. Wilson distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta –...

2012-06-14 07:28:42

Symbol: ZASP Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylumspinifex(Jacq.) DC. distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

2012-06-14 07:28:48

Symbol: ZAPU2 Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: ZanthoxylumpunctatumVahl distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

2012-06-14 07:28:50

Symbol: ZAMO Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylummonophyllum(Lam.) P. Wilson distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

More Articles (1280 articles) »
Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related